218 related articles for article (PubMed ID: 20683852)
1. Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: application of quality by design (QbD) principles.
Jiang C; Flansburg L; Ghose S; Jorjorian P; Shukla AA
Biotechnol Bioeng; 2010 Dec; 107(6):985-97. PubMed ID: 20683852
[TBL] [Abstract][Full Text] [Related]
2. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
3. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography.
Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y
Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320
[TBL] [Abstract][Full Text] [Related]
4. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
[TBL] [Abstract][Full Text] [Related]
5. Defining process design space for biotech products: case study of Pichia pastoris fermentation.
Harms J; Wang X; Kim T; Yang X; Rathore AS
Biotechnol Prog; 2008; 24(3):655-62. PubMed ID: 18412404
[TBL] [Abstract][Full Text] [Related]
6. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
Rathore AS; Yu M; Yeboah S; Sharma A
Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
[TBL] [Abstract][Full Text] [Related]
7. Application of hydrophobic interaction displacement chromatography for an industrial protein purification.
Sunasara KM; Xia F; Gronke RS; Cramer SM
Biotechnol Bioeng; 2003 May; 82(3):330-9. PubMed ID: 12599260
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a design space for biopharmaceutical purification processes using DoE.
Amadeo I; Mauro L; Ortí E; Forno G
Methods Mol Biol; 2014; 1129():11-27. PubMed ID: 24648063
[TBL] [Abstract][Full Text] [Related]
9. Influence of tryptophan tags on the purification of cutinase, secreted by a recombinant Saccharomyces cerevisiae, using cationic expanded bed adsorption and hydrophobic interaction chromatography.
Lienqueo ME; Salazar O; Calado CR; Fonseca LP; Cabral JM
Biotechnol Lett; 2008 Aug; 30(8):1353-8. PubMed ID: 18365751
[TBL] [Abstract][Full Text] [Related]
10. Purification of an Fc-fusion biologic: clearance of multiple product related impurities by hydrophobic interaction chromatography.
Evans DR; Macniven RP; Labanca M; Walker J; Notarnicola SM
J Chromatogr A; 2008 Jan; 1177(2):265-71. PubMed ID: 17692855
[TBL] [Abstract][Full Text] [Related]
11. Considerations for operational space definition and optimization of a no-salt flowthrough hydrophobic interaction chromatography purification step.
Dilks AT; Gilchrist J; Lam Y; Nicholes N; Stanley B
Biotechnol Prog; 2023; 39(4):e3351. PubMed ID: 37102582
[TBL] [Abstract][Full Text] [Related]
12. Lysozyme retention on hydrophobic interaction chromatography predicts resin performance at large scale.
Riske FJ; Smith MA; Zhang C; White KH
Biotechnol Appl Biochem; 2009 Oct; 54(3):157-62. PubMed ID: 19650769
[TBL] [Abstract][Full Text] [Related]
13. Advances in product release strategies and impact on bioprocess design.
Balasundaram B; Harrison S; Bracewell DG
Trends Biotechnol; 2009 Aug; 27(8):477-85. PubMed ID: 19573944
[TBL] [Abstract][Full Text] [Related]
14. Multi-dimensional fractionation and characterization of crude protein mixtures: toward establishment of a database of protein purification process development parameters.
Nfor BK; Ahamed T; Pinkse MW; van der Wielen LA; Verhaert PD; van Dedem GW; Eppink MH; van de Sandt EJ; Ottens M
Biotechnol Bioeng; 2012 Dec; 109(12):3070-83. PubMed ID: 22688729
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
[TBL] [Abstract][Full Text] [Related]
16. Preparative purification of a recombinant protein by hydrophobic interaction chromatography: modulation of selectivity by the use of chaotropic additives.
Shukla AA; Peterson J; Sorge L; Lewis P; Thomas S; Waugh S
Biotechnol Prog; 2002; 18(3):556-64. PubMed ID: 12052073
[TBL] [Abstract][Full Text] [Related]
17. Development of a polishing step using a hydrophobic interaction membrane adsorber with a PER.C6-derived recombinant antibody.
Kuczewski M; Fraud N; Faber R; Zarbis-Papastoitsis G
Biotechnol Bioeng; 2010 Feb; 105(2):296-305. PubMed ID: 19739096
[TBL] [Abstract][Full Text] [Related]
18. Modeling of protein monomer/aggregate purification and separation using hydrophobic interaction chromatography.
McCue JT; Engel P; Ng A; Macniven R; Thömmes J
Bioprocess Biosyst Eng; 2008 Apr; 31(3):261-75. PubMed ID: 18205016
[TBL] [Abstract][Full Text] [Related]
19. Process development for robust removal of aggregates using cation exchange chromatography in monoclonal antibody purification with implementation of quality by design.
Xu Z; Li J; Zhou JX
Prep Biochem Biotechnol; 2012; 42(2):183-202. PubMed ID: 22394066
[TBL] [Abstract][Full Text] [Related]
20. Rational and systematic protein purification process development: the next generation.
Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
